India · Delayed Price · Currency is INR Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 4.04 billion. The enterprise value is 4.20 billion.
| Market Cap | 4.04B |
| Enterprise Value | 4.20B |
Important Dates
The last earnings date was Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medico Remedies has 82.98 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 82.98M |
| Shares Outstanding | 82.98M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 74.96% |
| Owned by Institutions (%) | 1.20% |
| Float | 19.04M |
Valuation Ratios
The trailing PE ratio is 30.83.
| PE Ratio | 30.83 |
| Forward PE | n/a |
| PS Ratio | 1.96 |
| PB Ratio | 5.36 |
| P/TBV Ratio | 5.36 |
| P/FCF Ratio | 291.96 |
| P/OCF Ratio | 68.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.65, with an EV/FCF ratio of 303.12.
| EV / Earnings | 32.00 |
| EV / Sales | 2.03 |
| EV / EBITDA | 24.65 |
| EV / EBIT | 30.12 |
| EV / FCF | 303.12 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.66 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 13.87 |
| Interest Coverage | 7.71 |
Financial Efficiency
Return on equity (ROE) is 19.02% and return on invested capital (ROIC) is 12.01%.
| Return on Equity (ROE) | 19.02% |
| Return on Assets (ROA) | 6.37% |
| Return on Invested Capital (ROIC) | 12.01% |
| Return on Capital Employed (ROCE) | 18.39% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | 9.69M |
| Profits Per Employee | 615,737 |
| Employee Count | 213 |
| Asset Turnover | 1.51 |
| Inventory Turnover | 5.33 |
Taxes
In the past 12 months, Medico Remedies has paid 49.44 million in taxes.
| Income Tax | 49.44M |
| Effective Tax Rate | 27.38% |
Stock Price Statistics
The stock price has decreased by -11.20% in the last 52 weeks. The beta is 0.56, so Medico Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -11.20% |
| 50-Day Moving Average | 40.82 |
| 200-Day Moving Average | 45.51 |
| Relative Strength Index (RSI) | 71.88 |
| Average Volume (20 Days) | 13,071 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 2.06 billion and earned 131.15 million in profits. Earnings per share was 1.58.
| Revenue | 2.06B |
| Gross Profit | 550.50M |
| Operating Income | 139.32M |
| Pretax Income | 180.60M |
| Net Income | 131.15M |
| EBITDA | 170.27M |
| EBIT | 139.32M |
| Earnings Per Share (EPS) | 1.58 |
Balance Sheet
The company has 37.51 million in cash and 192.04 million in debt, with a net cash position of -154.53 million or -1.86 per share.
| Cash & Cash Equivalents | 37.51M |
| Total Debt | 192.04M |
| Net Cash | -154.53M |
| Net Cash Per Share | -1.86 |
| Equity (Book Value) | 754.75M |
| Book Value Per Share | 9.15 |
| Working Capital | 512.75M |
Cash Flow
In the last 12 months, operating cash flow was 58.74 million and capital expenditures -44.90 million, giving a free cash flow of 13.85 million.
| Operating Cash Flow | 58.74M |
| Capital Expenditures | -44.90M |
| Depreciation & Amortization | 30.95M |
| Net Borrowing | -5.50M |
| Free Cash Flow | 13.85M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 26.67%, with operating and profit margins of 6.75% and 6.35%.
| Gross Margin | 26.67% |
| Operating Margin | 6.75% |
| Pretax Margin | 8.75% |
| Profit Margin | 6.35% |
| EBITDA Margin | 8.25% |
| EBIT Margin | 6.75% |
| FCF Margin | 0.67% |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 3.24% |
| FCF Yield | 0.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Mar 16, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |